Book now

Accolades: Research collaboration awarded TxSCO recognition

HCMRI international researcher & Principal Investigator honored as recipient of the 2023 Texas Society of Clinical Oncology (TxSCO) research abstract competition with award at annual TxSCO conference for research on Experimental Treatment of Metastatic Breast Cancer Progression in the Thoracic Cavity performed in collaboration with University of Texas Health Science Center at Houston | UTHealth-Houston colleagues. TxSCO: https://www.accc-cancer.org/state-societies/Texas/about

Specialties & services

We offer a wide range of clinical research services with high quality data outcomes
In addition to leading research, we offer a range of services including global clinical research, drug discovery, medical device development, and clinical trial budgeting, all designed to help our partner-collaborators achieve their goals and improve the cancer burden amongst the Hispanic population. HCMRI minimizes the disruption in the personal lives of cancer patients who must travel to various centers to gain access to a clinical trial by being strategically engaged in clinical and translational research that serves and benefits the Hispanic community.

Vascular

Our Principal Investigators (PI's) have multiple analytical services and biometric quantitative technologies to assist with bench-to-bedside analysis, clinical trial budget development, and collaborative clinical research in vascular and metastatic cancer research infiltrating distant organ sites.
Learn more

Endocrinology & Breast

Our Principal Investigators (PI's) have multiple analytical services and biometric quantitative technologies to assist with bench-to-bedside analysis, clinical trial budget development, and collaborative clinical research in breast and thyroid cancer clinical studies.
Learn more

Lab services & clinical budgets

Our Principal Investigators (PI's) and experienced healthcare management executives have multiple analytical services and EMR integrative technologies to assist with bench-to-bedside analysis, clinical trial budget development, and collaborative clinical research.
Learn more

Pediatrics

Our Principal Investigators (PI's) have multiple analytical services and biometric quantitative technologies to assist with bench-to-bedside analysis, clinical trial budget development, and collaborative clinical research in childhood cancer studies, childhood Acute Myeloid Leukemia (AML), and childhood Acute Lymphoblastic Leukemia (ALL).
Learn more

Dermatology

Our Principal Investigators (PI's) and healthcare management executives have multiple analytical services and biometric quantitative technologies to assist with bench-to-bedside analysis, clinical trial budget development, and collaborative clinical research in skin cancer clinical research, and Melanoma studies.
Learn more

Head/Neck, Thoracic Sarcoma

Physician-Scientist (PI's) and healthcare management executives with expertise in Head and Neck, Thoracic oncology, sarcoma, bone & orthopedic oncology clinical research studies.
Learn more
Experience
Society of Clinical Research Association (SoCRA) certified-Principal Investigators, healthcare management executives, and clinical research coordinators with CITI training, continued ICH/GCP/CFR education, and internationally-accepted standard of knowledge, education, experience as Certified Clinical Research Professionals (CCRP®s) in the clinical research community. We have over 17 years of bench to bedside research experience & metabolomics/ proteomics/ genomics post-doctoral training paired with prior clinical research experience with advanced technologies at leading biomedical institutions (Baylor College of Medicine) and global cancer research hospitals (University of Texas MD Anderson Cancer Center) to advance clinical translational and immunotherapeutic discoveries that impact cancer research. Learn more https://www.socra.org/
Innovation
International research collaboration between investigators across 3 countries in North America (radio-oncologist & HCMRI co-PI) publication of solitary plasmacytoma, malignancy characterized by monoclonal proliferation of abnormal plasma cells in bone tissue or extramedullary, and absence of multiple myeloma-defining clinical characteristics (bone lesions, end-organ damage, plasmacytosis, anemia, hypercalcemia). Solitary extramedullary plasmacytomas occur in head & neck-either surgical approach or localized external beam radiotherapy as definitive treatment. EBRT has therapeutic effects in SEP management as noninvasive modality. Learn morehttps://pubmed.ncbi.nlm.nih.gov/37288179/
Diversity
Diversity-oriented patient recruitment focused on the Hispanic community with integration of patient-advocates and clinical research staff. We believe that patients who are eligible to be in a clinical research study should have the opportunity to participate, and that ethnic, racial or financial status should not be a limiting factor. HCMRI provides the same opportunities that major institutions offer to patients who are seen at community clinics in a setting close to home. Our adult and pediatric partner clinics span across the state to include the Rio Grande Valley, San Antonio, Houston/Gulf Coast, and east Texas communities.
Contact Information
Contact us now
Email
info@hcmri.org
Phone
(832) 801-8745
Social media
The Hispanic Cancer Medicine Research Institute (HCMRI) is an Affirmative Action/Equal Opportunity Employer: Minorities, Women, Veterans, and Individuals with Disabilities. © Copyright 2023 Hispanic Cancer Medicine Research Institute. All rights reserved. All registered trademarks herein are the property of HCMRI or their respective owners.